Yang et al. demonstrated that butein inhibits the proliferation of breast cancer cells via the generation of ROS and the modulation of ERK and p38 activities, showing that pre-treatment with the antioxidant, N-acetyl cysteine (NAC), prevented butein-induced apoptosis [110]. Here, MAPK1 is linked to breast cancer.